CID 134517711

Soquelitinib

Structural Information

Molecular Formula
C25H30N4O4S2
SMILES
C[C@@H]1CN(CCCN1C(=O)C=C)C(=O)C2=C(C=C(C(=C2)SC3=CN=C(S3)NC(=O)C4CC4)C)OC
InChI
InChI=1S/C25H30N4O4S2/c1-5-21(30)29-10-6-9-28(14-16(29)3)24(32)18-12-20(15(2)11-19(18)33-4)34-22-13-26-25(35-22)27-23(31)17-7-8-17/h5,11-13,16-17H,1,6-10,14H2,2-4H3,(H,26,27,31)/t16-/m1/s1
InChIKey
KNCWSXRTKLTULH-MRXNPFEDSA-N
Compound name
N-[5-[4-methoxy-2-methyl-5-[(3R)-3-methyl-4-prop-2-enoyl-1,4-diazepane-1-carbonyl]phenyl]sulfanyl-1,3-thiazol-2-yl]cyclopropanecarboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

7
Patents

514.17084 Da
Monoisotopic Mass

3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 515.17812 213.9
[M+Na]+ 537.16006 216.7
[M-H]- 513.16356 222.1
[M+NH4]+ 532.20466 213.6
[M+K]+ 553.13400 214.9
[M+H-H2O]+ 497.16810 204.8
[M+HCOO]- 559.16904 218.6
[M+CH3COO]- 573.18469 241.9
[M+Na-2H]- 535.14551 205.2
[M]+ 514.17029 215.3
[M]- 514.17139 215.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe